ZBTB21

Summary

ZBTB21 (zinc finger and BTB domain containing 21, HGNC:13083) is a protein-coding gene on chromosome 21q22.3, encoding Zinc finger and BTB domain-containing protein 21 (Q9ULJ3). Acts as a transcription repressor.

Enables several functions, including DNA-binding transcription repressor activity, RNA polymerase II-specific; POZ domain binding activity; and methyl-CpG binding activity. Involved in negative regulation of transcription by RNA polymerase II. Located in cytosol and nucleoplasm.

Source: NCBI Gene 49854 — RefSeq curated summary.

At a glance

• GWAS associations: 1
• Clinical variants (ClinVar): 170 total
• Druggable target: yes
• MANE Select transcript: NM_001098402

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:13083
Approved symbol	ZBTB21
Name	zinc finger and BTB domain containing 21
Location	21q22.3
Locus type	gene with protein product
Status	Approved
Aliases	KIAA1227
Ensembl gene	ENSG00000173276
Ensembl biotype	protein_coding
OMIM	616485
Entrez	49854

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 9 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000310826, ENST00000398497, ENST00000398499, ENST00000398505, ENST00000398511, ENST00000425521, ENST00000449949, ENST00000465968, ENST00000881815, ENST00000932835

RefSeq mRNA: 5 — MANE Select: NM_001098402 NM_001098402, NM_001098403, NM_001320729, NM_001320731, NM_020727

CCDS: CCDS13678, CCDS42934

Canonical transcript exons

ENST00000310826 — 3 exons

Exon	Start	End
ENSE00001485132	42002897	42002961
ENSE00001547265	41986831	41994108
ENSE00003849528	42010252	42010360

Expression profiles

Bgee: expression breadth ubiquitous, 257 present calls, max score 97.06.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 17.3239 / max 179.2426, expressed in 1802 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter ID	TPM avg	Samples expressed
190578	13.9246	1768
190577	2.9874	1266
190576	0.2800	116
190575	0.1320	49

Top tissues by expression

258 total, by Bgee expression score (0-100, higher = more expressed):

Tissue	Anatomy ID	Expression score	Quality
cauda epididymis	UBERON:0004360	97.06	gold quality
endothelial cell	CL:0000115	95.76	gold quality
epithelial cell of pancreas	CL:0000083	94.06	gold quality
corpus epididymis	UBERON:0004359	93.98	gold quality
secondary oocyte	CL:0000655	93.55	gold quality
caput epididymis	UBERON:0004358	93.51	gold quality
Brodmann (1909) area 23	UBERON:0013554	91.89	gold quality
cartilage tissue	UBERON:0002418	91.84	gold quality
mucosa of paranasal sinus	UBERON:0005030	89.88	gold quality
calcaneal tendon	UBERON:0003701	89.30	gold quality
lower lobe of lung	UBERON:0008949	88.59	gold quality
visceral pleura	UBERON:0002401	88.28	gold quality
male germ line stem cell (sensu Vertebrata) in testis	CL:0000089 ∩ UBERON:0000473	87.40	gold quality
parietal pleura	UBERON:0002400	86.89	gold quality
bone marrow cell	CL:0002092	86.88	gold quality
superficial temporal artery	UBERON:0001614	86.66	gold quality
oocyte	CL:0000023	86.36	gold quality
kidney epithelium	UBERON:0004819	86.18	gold quality
pancreatic ductal cell	CL:0002079	85.99	gold quality
palpebral conjunctiva	UBERON:0001812	85.92	gold quality
bone marrow	UBERON:0002371	85.81	gold quality
mammary duct	UBERON:0001765	85.75	gold quality
epithelium of mammary gland	UBERON:0003244	85.71	gold quality
placenta	UBERON:0001987	85.69	gold quality
mammalian vulva	UBERON:0000997	85.44	gold quality
adrenal tissue	UBERON:0018303	85.13	gold quality
primary visual cortex	UBERON:0002436	85.09	gold quality
middle temporal gyrus	UBERON:0002771	85.09	gold quality
islet of Langerhans	UBERON:0000006	85.05	gold quality
eye	UBERON:0000970	85.03	gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

Experiment	Marker?	Max mean expression
E-ANND-3	yes	7.38

Regulation

Is transcription factor: yes

JASPAR motifs

Motif	Name	Family
MA2487.1	ZBTB21	Factors with multiple dispersed zinc fingers

JASPAR matrix evidence (PMIDs): PMID:38959316

miRNA regulators (miRDB)

200 targeting ZBTB21, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNA	Max score	Avg score	miRNA target_count
HSA-MIR-4795-3P	100.00	74.62	4024
HSA-MIR-340-5P	100.00	72.50	4437
HSA-MIR-3163	100.00	77.23	8605
HSA-MIR-3646	100.00	73.56	5283
HSA-MIR-3613-3P	100.00	76.36	7965
HSA-MIR-548C-3P	99.99	74.01	7587
HSA-MIR-4282	99.99	75.36	6408
HSA-MIR-3662	99.99	73.82	5684
HSA-MIR-513B-5P	99.99	69.96	2150
HSA-MIR-186-5P	99.99	70.83	3707
HSA-MIR-485-3P	99.98	70.68	1585
HSA-MIR-539-3P	99.98	70.74	1616
HSA-MIR-548P	99.98	72.25	3784
HSA-MIR-548N	99.98	71.94	4170
HSA-MIR-12136	99.98	72.81	5713
HSA-MIR-3688-3P	99.97	72.02	2834
HSA-MIR-3148	99.97	75.06	6478
HSA-MIR-302C-5P	99.97	72.56	3642
HSA-MIR-6778-3P	99.96	67.29	2693
HSA-MIR-548AA	99.96	70.64	3753
HSA-MIR-548AP-3P	99.96	70.64	3753
HSA-MIR-548T-3P	99.96	70.64	3753
HSA-MIR-3658	99.96	73.87	4379
HSA-MIR-551B-5P	99.96	71.28	3493
HSA-MIR-548AT-5P	99.96	70.83	2666
HSA-MIR-590-3P	99.96	74.34	6478
HSA-MIR-1468-3P	99.96	72.74	3797
HSA-MIR-1250-3P	99.96	70.04	4038
HSA-MIR-559	99.95	72.28	3609
HSA-MIR-548AB	99.95	71.31	3488

Literature-anchored findings (GeneRIF, showing 2)

• ZNF295 may be involved in the bi-directional control of gene expression in concert with ZFP161 (PMID:15629158)
• Genotyping was accomplished on Infinium Human610-QUAD version 1. In the ilSIRENTE population, genetic variants in ZNF295 and C2CD2 (rs928874 and rs1788355) on chromosome 21q22.3, were significantly associated with the 4-meter gait speed (PMID:29158487)

Cross-species orthologs

3 orthologs

Organism	Symbol	Gene ID
danio_rerio	zbtb21	ENSDARG00000043285
mus_musculus	Zbtb21	ENSMUSG00000046962
rattus_norvegicus	Zbtb21	ENSRNOG00000001623

Paralogs (28): ZNF280C (ENSG00000056277), ZBTB25 (ENSG00000089775), PRDM13 (ENSG00000112238), BCL6 (ENSG00000113916), FEZF1 (ENSG00000128610), ZBTB46 (ENSG00000130584), PRDM12 (ENSG00000130711), ZNF280D (ENSG00000137871), NACC2 (ENSG00000148411), FEZF2 (ENSG00000153266), ZBTB7B (ENSG00000160685), NACC1 (ENSG00000160877), BCL6B (ENSG00000161940), GFI1 (ENSG00000162676), GFI1B (ENSG00000165702), ZBTB49 (ENSG00000168826), ZNF280A (ENSG00000169548), ZNF581 (ENSG00000171425), ZNF524 (ENSG00000171443), ZBTB26 (ENSG00000171448), ZNF683 (ENSG00000176083), ZBTB33 (ENSG00000177485), ZBTB3 (ENSG00000185670), ZBTB6 (ENSG00000186130), ZBTB14 (ENSG00000198081), ZBTB12 (ENSG00000204366), ZNF580 (ENSG00000213015), ZNF280B (ENSG00000275004)

Protein

Protein identifiers

Zinc finger and BTB domain-containing protein 21 — Q9ULJ3 (reviewed: Q9ULJ3)

Alternative names: Zinc finger protein 295

All UniProt accessions (3): Q9ULJ3, E7EVF9, Q5KS07

UniProt curated annotations — full annotation on UniProt →

Function. Acts as a transcription repressor.

Subunit / interactions. Homodimer. Interacts with ZBTB14.

Subcellular location. Nucleus.

Tissue specificity. Ubiquitous in fetal and adult tissues.

Isoforms (2)

UniProt ID	Names	Canonical?
Q9ULJ3-1	1, ZNF295L	yes
Q9ULJ3-2	2, ZNF295S

RefSeq proteins (5): NP_001091872, NP_001091873, NP_001307658, NP_001307660, NP_065778 (=MANE)

Domains & families (InterPro)

ID	Name	Type
IPR000210	BTB/POZ_dom	Domain
IPR011333	SKP1/BTB/POZ_sf	Homologous_superfamily
IPR013087	Znf_C2H2_type	Domain
IPR036236	Znf_C2H2_sf	Homologous_superfamily
IPR041011	Znf_C2H2_6	Domain

Pfam: PF00096, PF00651, PF18450

UniProt features (68 total): cross-link 21, modified residue 11, region of interest 8, zinc finger region 8, compositionally biased region 6, helix 5, sequence variant 2, turn 2, chain 1, domain 1, splice variant 1, sequence conflict 1, strand 1

Structure

Experimental structures (PDB)

1 structures.

PDB	Method	Resolution (Å)
1WJP	SOLUTION NMR

Predicted structure (AlphaFold)

Model	pLDDT	Fraction very-high
AF-Q9ULJ3-F1	54.06	0.06

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (32): 345, 381, 411, 422, 431, 434, 435, 438, 605, 714, 1003, 40, 40, 255, 266, 273, 312, 337, 383, 430 …

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 162 (showing top): TGCGCANK_UNKNOWN, CREBP1_Q2, GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP, CREB_Q4, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5, E4F1_Q6, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5, PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP, CREBP1_01, chr21q22, P53_DECAMER_Q2, ATF_01, CREB_01, LEE_RECENT_THYMIC_EMIGRANT, SANSOM_APC_MYC_TARGETS

GO Biological Process (3): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of transcription by RNA polymerase II (GO:0006357), negative regulation of DNA-templated transcription (GO:0045892)

GO Molecular Function (9): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), zinc ion binding (GO:0008270), methyl-CpG binding (GO:0008327), POZ domain binding (GO:0031208), identical protein binding (GO:0042802), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (3): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytosol (GO:0005829)

GO top-level categories

Rollup of top GO terms by namespace:

Category	Terms
regulation of transcription by RNA polymerase II	2
transcription by RNA polymerase II	2
regulation of DNA-templated transcription	2
RNA polymerase II transcription regulatory region sequence-specific DNA binding	2
cellular anatomical structure	2
negative regulation of DNA-templated transcription	1
DNA-templated transcription	1
negative regulation of RNA biosynthetic process	1
chromatin	1
DNA-binding transcription factor activity	1
negative regulation of transcription by RNA polymerase II	1
DNA-binding transcription factor activity, RNA polymerase II-specific	1
DNA-binding transcription repressor activity	1
transition metal ion binding	1
nucleotide binding	1
sequence-specific DNA binding	1
protein domain specific binding	1
protein binding	1
nucleic acid binding	1
binding	1
cation binding	1
intracellular membrane-bounded organelle	1
nuclear lumen	1
cytoplasm	1

Protein interactions and networks

STRING

962 interactions, top by confidence (×1000):

Protein A	Protein B	Partner UniProt	Score
ZBTB21	C2CD2	Q9Y426	610
ZBTB21	RRP1B	Q14684	586
ZBTB21	LIPI	Q6XZB0	553
ZBTB21	PDXK	O00764	530
ZBTB21	CXorf58	Q96LI9	512
ZBTB21	LRRC42	Q9Y546	453
ZBTB21	RIPK4	P57078	448
ZBTB21	TRARG1	Q8IXB3	448
ZBTB21	CRELD1	Q96HD1	428
ZBTB21	DYRK1A	Q13627	420
ZBTB21	HUNK	P57058	412
ZBTB21	ZNF697	Q5TEC3	412
ZBTB21	PRDM15	P57071	405
ZBTB21	PPP1R14D	Q9NXH3	405
ZBTB21	VPS26C	O14972	394
ZBTB21	UMODL1	Q5DID0	394

IntAct

180 interactions, top by confidence:

A	B	Type	Score
ZBTB21	YWHAG	psi-mi:“MI:0915”(physical association)	0.900
YWHAQ	WDR62	psi-mi:“MI:0914”(association)	0.830
KBTBD7	METTL15	psi-mi:“MI:0914”(association)	0.730
PPP2R2D	YEATS4	psi-mi:“MI:0914”(association)	0.730
FBXL17	BACH1	psi-mi:“MI:0914”(association)	0.730
PPP2R2B	MYO9A	psi-mi:“MI:0914”(association)	0.640
CETN1	SFI1	psi-mi:“MI:0914”(association)	0.640
CHCHD4	SSNA1	psi-mi:“MI:0914”(association)	0.640
KPNA1	TCERG1	psi-mi:“MI:0914”(association)	0.640
ABTB1	ZBTB21	psi-mi:“MI:0915”(physical association)	0.620
YWHAH	PLEKHG3	psi-mi:“MI:0914”(association)	0.610
POLE2	CYP4F12	psi-mi:“MI:0914”(association)	0.560
YWHAG	SHTN1	psi-mi:“MI:0914”(association)	0.560
GSTA1	GSTA4	psi-mi:“MI:0914”(association)	0.530
PRICKLE3	SIAH2	psi-mi:“MI:0914”(association)	0.530
NAP1L5	RPS2	psi-mi:“MI:0914”(association)	0.530
ABTB1	VARS1	psi-mi:“MI:0914”(association)	0.530
YWHAQ	IGLC7	psi-mi:“MI:0914”(association)	0.530
YWHAB	SHTN1	psi-mi:“MI:0914”(association)	0.530
YWHAZ	BLTP3B	psi-mi:“MI:0914”(association)	0.530
CASQ2	PES1	psi-mi:“MI:0914”(association)	0.530
CLEC11A	VWA8	psi-mi:“MI:0914”(association)	0.530
PRICKLE3	TUBG1	psi-mi:“MI:0914”(association)	0.530

BioGRID (198): ZBTB21 (Affinity Capture-MS), ZBTB21 (Affinity Capture-MS), ZBTB21 (Affinity Capture-MS), ZBTB21 (Affinity Capture-MS), ZBTB21 (Affinity Capture-MS), ZBTB21 (Affinity Capture-MS), ZBTB21 (Proximity Label-MS), ZBTB21 (Affinity Capture-MS), ZBTB21 (Affinity Capture-MS), ZBTB21 (Affinity Capture-MS), ZBTB21 (Affinity Capture-MS), ZBTB21 (Affinity Capture-MS), ZBTB21 (Affinity Capture-MS), ZBTB21 (Affinity Capture-MS), ZBTB21 (Affinity Capture-MS)

ESM2 similar proteins: A0A5K7RLP0, A1YEX3, A7YWH3, B1WBU4, O15151, O35618, O43298, O88850, P24278, P97303, Q01954, Q0V8G8, Q15916, Q17RG1, Q562E2, Q5RC05, Q5RDQ6, Q5SXH7, Q5TC79, Q5VYS8, Q5W0Q7, Q5XIN1, Q6ZPY5, Q6ZSB9, Q6ZU67, Q7ZUW7, Q7ZYI3, Q8BLK9, Q8BSV3, Q8IW35, Q8K088, Q8N680, Q8N7W2, Q8TCN5, Q8VHI4, Q8WW38, Q90W33, Q96BR9, Q96S38, Q99ME3

Diamond homologs: A0A1B8YAB1, A1YPR0, B0WWP2, B1H285, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, C9JR72, D3Z8N4, E0CZ16, G3X9X1, O15062, O88939, O93567, O95365, P28575, P41182, P41183, Q08CL3, Q08DK3, Q13105, Q16RL8, Q2M0J9, Q3UQV5, Q52KB5, Q5EXX3, Q5R7B8, Q5RDY3, Q5TC79, Q5ZI33, Q5ZKD9, Q5ZM39, Q60821

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 194 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

Pathway	Partners	Fold	FDR
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	9	46.5×	4e-11
Activation of BAD and translocation to mitochondria	7	41.0×	2e-08
SARS-CoV-1 targets host intracellular signalling and regulatory pathways	7	36.2×	4e-08
Activation of BH3-only proteins	7	26.7×	3e-07
RHO GTPases activate PKNs	9	22.0×	2e-08
Intrinsic Pathway for Apoptosis	7	15.8×	1e-05
SARS-CoV-1-host interactions	10	13.5×	2e-07
FOXO-mediated transcription	5	12.9×	6e-04

GO biological processes:

GO term	Partners	Fold	FDR
protein targeting	6	12.5×	4e-03
negative regulation of translation	7	7.8×	1e-02
intracellular protein localization	10	6.0×	4e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

170 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	154
Likely benign	8
Benign	0

Top pathogenic / likely-pathogenic (0)

SpliceAI

786 predictions. Top by Δscore:

Variant	Effect	Δscore
21:42010246:ACTC:A	donor_loss	1.0000
21:42010248:TCACC:T	donor_loss	1.0000
21:42010249:CA:C	donor_loss	1.0000
21:42010250:A:AC	donor_gain	1.0000
21:42010250:A:T	donor_loss	1.0000
21:42010251:C:CC	donor_gain	1.0000
21:42010251:CCGG:C	donor_gain	1.0000
21:42010251:CCGGT:C	donor_gain	1.0000
21:42009445:C:CA	donor_gain	0.9900
21:42010245:TAC:T	donor_loss	0.9900
21:42010246:A:AC	donor_gain	0.9900
21:42010247:C:CC	donor_gain	0.9900
21:42010250:AC:A	donor_gain	0.9900
21:42010251:CC:C	donor_gain	0.9900
21:42010251:CCG:C	donor_gain	0.9900
21:41994104:TTTAT:T	acceptor_gain	0.9800
21:41994106:TAT:T	acceptor_gain	0.9800
21:41994109:C:CC	acceptor_gain	0.9800
21:42010244:TTAC:T	donor_loss	0.9800
21:41993904:ATTTT:A	donor_gain	0.9700
21:41994105:TTAT:T	acceptor_gain	0.9700
21:41994106:TATC:T	acceptor_loss	0.9700
21:41994108:TCTA:T	acceptor_loss	0.9700
21:41994109:CTA:C	acceptor_loss	0.9700
21:41994117:CAAAA:C	acceptor_loss	0.9700
21:42002896:CCA:C	donor_gain	0.9700
21:42010049:TGGGA:T	donor_gain	0.9700
21:42008650:T:C	donor_gain	0.9600
21:42002959:CTT:C	acceptor_gain	0.9500
21:42008188:T:TA	donor_gain	0.9500

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000112195 (21:42009807 C>G), RS1000169708 (21:42009012 G>C), RS1000536399 (21:42009660 G>A), RS1000635288 (21:42005579 G>A,C), RS1000656183 (21:42010469 A>C,G,T), RS1001005770 (21:42006796 C>A,G,T), RS1001026992 (21:41987976 C>A), RS1001103996 (21:42000636 G>C), RS1001351871 (21:42006442 AAAT>A), RS1001531586 (21:42005112 A>T), RS1001591320 (21:42011533 A>G), RS1001644965 (21:42011356 C>G), RS1002002943 (21:41998708 G>T), RS1002082126 (21:41994773 G>A), RS1002285464 (21:42001225 G>C)

Disease associations

OMIM: gene MIM:616485 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

Study	Trait	p-value
GCST002770_1	Hand grip strength	6.000000e-07

EFO canonical traits (1, from GWAS)

EFO ID	Trait name
EFO:0006941	grip strength measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL5069368 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

60 total (human), top 30 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
Valproic Acid	decreases expression, increases expression, affects cotreatment	5
trichostatin A	affects cotreatment, decreases expression	3
sodium arsenite	decreases expression, increases expression	3
Cyclosporine	increases expression	3
Cadmium Chloride	decreases expression, increases abundance, increases expression	3
Air Pollutants	decreases expression, increases abundance, increases expression	2
Tetrachlorodibenzodioxin	affects expression, increases expression	2
Tobacco Smoke Pollution	increases expression	2
Particulate Matter	increases abundance, increases expression, decreases expression	2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide	decreases expression	1
FR900359	affects phosphorylation	1
TAK-243	decreases sumoylation	1
triphenyl phosphate	affects expression	1
bisphenol A	increases expression	1
deoxynivalenol	increases expression	1
beta-lapachone	increases expression	1
tris(1,3-dichloro-2-propyl)phosphate	increases expression	1
coumarin	decreases phosphorylation	1
15-acetyldeoxynivalenol	increases expression	1
diethyl malate	increases expression	1
di-n-butylphosphoric acid	affects expression	1
pentabromodiphenyl ether	increases expression	1
CGP 52608	affects binding, increases reaction	1
2-palmitoylglycerol	increases expression	1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	affects cotreatment, decreases expression	1
torcetrapib	increases expression	1
abrine	increases expression	1
2,2’,4,4’-tetrabromodiphenyl ether	increases expression	1
dorsomorphin	affects cotreatment, decreases expression	1
eprenetapopt	affects expression, affects reaction	1

ChEMBL screening assays

2 unique, capped per target: 2 binding

Representative assays (with source publication via chembl_document):

Assay ID	Type	Description	Source paper
CHEMBL5059501	Binding	Proteomics fold change data (SUDHL4 cells, 1h)	Data for DCP probe CCT369260

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

Cellosaurus	Name	Category	Sex
CVCL_XV89	HEK293 eGFP-ZBTB21	Transformed cell line	Female

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.